CIN- L67120MH1995PLC084899

Login

Login

Generate password

Forgot Customer Code

Would you like to create a personalised login id for logging in to Emkay Website ?

Change Personalised Login ID

Aarti Pharmalabs Ltd.

NSE : AARTIPHARMEQ BSE : 543748 ISIN CODE : INE0LRU01027Industry : Pharmaceuticals

News

  • Aarti Pharmalabs has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2026 16 Apr 2026 | 12:10 | Dion Global

    As of March 2026 43.08% is owned by Promoters and 56.92% by Public. Among Promoters holding Indian Promoters holds 42.91% and Foreign Promoters holds...more...

  • Aarti Pharmalabs - Certificate under SEBI (Depositories and Participants) Regulations, 2018 07 Apr 2026 | 13:20 | Dion Global

    Aarti Pharmalabs Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations 2018more...

  • Aarti Pharmalabs - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 07 Apr 2026 | 13:18 | Dion Global

    Please find our intimation on captioned subjectmore...

  • Aarti Pharmalabs - Copy of Newspaper Publication 07 Apr 2026 | 13:14 | Dion Global

    Aarti Pharmalabs Limited has informed the Exchange about Copy of Newspaper Publicationmore...

  • Aarti Pharmalabs - Updates 04 Apr 2026 | 17:00 | Dion Global

    Aarti Pharmalabs Limited has informed the Exchange regarding Intimation Regarding Second 100-Day Campaign - Saksham Niveshak .more...

  • Aarti Pharmalabs - Intimation Regarding Second 100-Day Campaign - 'Saksham Niveshak' 04 Apr 2026 | 16:57 | Dion Global

    Please find our intimation on captioned subject.more...

  • Aarti Pharmalabs - Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulati 04 Apr 2026 | 10:24 | Dion Global

    The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of S...more...

  • Aarti Pharmalabs - Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulati 04 Apr 2026 | 10:23 | Dion Global

    The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 2...more...

  • Aarti Pharmalabs - Updates 27 Mar 2026 | 18:43 | Dion Global

    Aarti Pharmalabs Limited has informed the Exchange regarding Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements)...more...

  • Aarti Pharmalabs - Announcement under Regulation 30 (LODR)-Press Release / Media Release 27 Mar 2026 | 18:29 | Dion Global

    Please find our intimation in captioned subjectmore...

  • Aarti Pharmalabs - Trading Window 25 Mar 2026 | 14:44 | Dion Global

    Aarti Pharmalabs Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations...more...

  • Aarti Pharmalabs - Updates 24 Mar 2026 | 12:48 | Dion Global

    Aarti Pharmalabs Limited has informed the Exchange regarding Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requ...more...

  • Aarti Pharmalabs - Analysts/Institutional Investor Meet/Con. Call Updates 16 Feb 2026 | 11:05 | Dion Global

    Aarti Pharmalabs Limited has informed the Exchange about Transcriptmore...

  • Aarti Pharmalabs - Announcement under Regulation 30 (LODR)-Earnings Call Transcript 16 Feb 2026 | 11:00 | Dion Global

    Transcript of Q3 FY 26 Earnings Conference Callmore...

  • Aarti Pharmalabs - General Updates 13 Feb 2026 | 14:52 | Dion Global

    Aarti Pharmalabs Limited has informed the Exchange about Clarification Regarding Delay in Disclosure of Event to the Exchangemore...

  • Aarti Pharmalabs - Clarification Regarding Delay In Disclosure Of Event To The Exchange 13 Feb 2026 | 14:46 | Dion Global

    Please find enclosedmore...

  • Aarti Pharmalabs - Copy of Newspaper Publication 11 Feb 2026 | 12:48 | Dion Global

    Aarti Pharmalabs Limited has informed the Exchange about Copy of Newspaper Publicationmore...

  • Aarti Pharmalabs - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome 10 Feb 2026 | 22:34 | Dion Global

    Recording of the Earnings Conference call for Q3 FY 26more...

  • Aarti Pharmalabs - Analysts/Institutional Investor Meet/Con. Call Updates 10 Feb 2026 | 22:32 | Dion Global

    Aarti Pharmalabs Limited has informed the Exchange about Link of Recordingmore...

  • Aarti Pharmalabs - Updates 10 Feb 2026 | 13:48 | Dion Global

    Aarti Pharmalabs Limited has informed the Exchange regarding Corrigendum to Intimation of Record Datefor Dividend dated February 09 2026 .more...

DOW Jones45473.550.16%
Nasdaq21794.160.43%
S&P 5006496.040.22%
Nikkei 22543643.811.45%
Hang Seng25633.910.85%
Shanghai Composite3826.840.38%
Sensex76664.21-1.29%
NSE Index23897.95-1.13%
B500DIVL503607.49-1.30%
BSE 1000 10514.13-1.07%
BSE 100LCTMC8965.34-1.07%
BSE Auto 56681.68-0.78%

Commodity

Gold150212-0.03%
Silver2409890.34%
Copper1261.25209.28%
Crude Oil901840.62%
Lead201.549.93%
Mentha Oil1134.36.27%
Nickel1776131.58%

Currency

USD/INR 94.08(0.26 %)
GBP/INR 126.96(0.09 %)
EUR/INR 110.14(-0.10 %)
JPY/INR 0.59(0.08 %)
CAD/INR 68.68(0.04 %)
HKD/INR 12.01(0.25 %)